Suppr超能文献

一种膜相关雌激素受体在乳腺癌细胞中的特征及其对新型选择性配体激素治疗耐药性的贡献。

Characterization of a membrane-associated estrogen receptor in breast cancer cells and its contribution to hormone therapy resistance using a novel selective ligand.

机构信息

Department of Molecular and Functional Dynamics, Graduate School of Medicine, Tohoku University, Aoba-ku, Sendai, Miyagi, 980-8575, Japan.

Department of Molecular and Functional Dynamics, Graduate School of Medicine, Tohoku University, Aoba-ku, Sendai, Miyagi, 980-8575, Japan.

出版信息

J Steroid Biochem Mol Biol. 2020 Jul;201:105671. doi: 10.1016/j.jsbmb.2020.105671. Epub 2020 Apr 11.

Abstract

The estrogen receptor (ER) plays a role in the progression of hormone-dependent breast cancer and is a hormone therapy target. Estrogen acts as a transcription factor (genomic action) and also produces a quick non-genomic reaction through intracellular signaling pathways. The membrane associated ER (mER) may regulate both these signals and hormone therapy resistance. However, the details remain unclear because a reliable method to distinguish the signals induced by the estradiol (E2)-mER and E2-nuclear ER complex has not been established. In the present study, we prepared the novel ligand Qdot-6-E2, selective for mER, by coupling E2 with insoluble quantum dot nano-beads. We investigated the characteristics of mER signaling pathways and its contribution to hormone therapy resistance using different cell lines including estrogen depletion resistant (EDR) cells with different mechanisms. Qdot-6-E2 stimulated proliferation of nuclear ER-positive cells, but nuclear ER-negative cells showed no response. In addition, Qdot-6-E2 indirectly activated nuclear ER and increased mRNA expression of target genes. We confirmed that E2 was not dissociated from Qdot-6-E2 using a mammalian one-hybrid assay. We visually demonstrated that Qdot-6-E2 acts from the outside of cells. The gene expression profile induced by Qdot-6-E2-mER was different from that induced by E2-nuclear ER. The effect of anti-ER antibody, the GFP-ER fusion protein localization, and the effect of palmitoyl acyltransferase inhibitor also indicated the existence of mER. Regarding intracellular phosphorylation signaling pathways, the MAPK (Erk 1/2) and the PI3K/Akt pathways were both activated by Qdot-6-E2. In EDR cells, only nuclear ER-positive cells showed increased cell proliferation with increased localization of ERα to the membrane fraction. These findings suggested that Qdot-6-E2 reacts with ERα surrounding the cell membrane and that mER signals help the cells to survive under estrogen-depleted conditions by re-localizing the ER to use trace amounts of E2 more effectively. We expect that Qdot-6-E2 is a useful tool for studying the mER.

摘要

雌激素受体(ER)在激素依赖性乳腺癌的进展中发挥作用,是激素治疗的靶点。雌激素作为转录因子(基因组作用),也通过细胞内信号通路产生快速的非基因组反应。膜相关 ER(mER)可能调节这两种信号和激素治疗抵抗。然而,由于尚未建立区分雌二醇(E2)-mER 和 E2-核 ER 复合物诱导的信号的可靠方法,因此细节仍不清楚。在本研究中,我们通过将 E2 与不溶性量子点纳米珠偶联,制备了对 mER 具有选择性的新型配体 Qdot-6-E2。我们使用不同的细胞系,包括具有不同机制的雌激素耗竭抵抗(EDR)细胞,研究了 mER 信号通路的特征及其对激素治疗抵抗的贡献。Qdot-6-E2 刺激核 ER 阳性细胞的增殖,但核 ER 阴性细胞无反应。此外,Qdot-6-E2 间接激活核 ER 并增加靶基因的 mRNA 表达。我们使用哺乳动物单杂交测定法证实 E2 未从 Qdot-6-E2 中解离。我们直观地证明了 Qdot-6-E2 从细胞外部起作用。由 Qdot-6-E2-mER 诱导的基因表达谱与由 E2-核 ER 诱导的基因表达谱不同。抗 ER 抗体、GFP-ER 融合蛋白定位和棕榈酰转移酶抑制剂的作用也表明存在 mER。关于细胞内磷酸化信号通路,MAPK(Erk1/2)和 PI3K/Akt 通路均被 Qdot-6-E2 激活。在 EDR 细胞中,只有核 ER 阳性细胞显示出细胞增殖增加,并且 ERα 向质膜部分的定位增加。这些发现表明,Qdot-6-E2 与围绕细胞膜的 ERα 反应,并且 mER 信号通过将 ER 重新定位到质膜以更有效地利用痕量的 E2 来帮助细胞在雌激素耗尽的条件下存活。我们期望 Qdot-6-E2 是研究 mER 的有用工具。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验